ORAMED PHARMACEUTICALS INC. APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
ORAMED PHARMACEUTICALS INC. (ORMP) reported APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition of $36.43 thousand for the 9-month period ending 2014-05-31, per its 10-Q filed 2014-07-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition · last filed 2014-07-14
- ORAMED PHARMACEUTICALS INC. apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2014-05-31 was -$20.59K.
| Period end | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 65 month |
|---|---|---|---|---|---|
| 2014-05-31 | -$20.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-14 | $36.43K 10-Q · filed 2014-07-14 | |||
| 2014-02-28 | $57.02K 10-Q · filed 2014-04-10 | ||||
| 2013-08-31 | $156.25K 10-Q · filed 2014-04-10 | ||||
| 2012-08-31 | $70.29K 10-Q · filed 2014-04-10 | ||||
| 2011-08-31 | $26.73K 10-Q · filed 2014-04-10 | ||||
| 2010-08-31 | $116.94K 10-Q · filed 2014-04-10 | ||||
| 2009-08-31 | $117.17K 10-Q · filed 2014-04-10 | ||||
| 2008-08-31 | $203.98K 10-Q · filed 2014-04-10 | ||||
| 2007-08-31 | $177.78K 10-Q · filed 2014-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |